comparemela.com

Latest Breaking News On - வருவாய் புள்ளிவிவரங்கள் - Page 1 : comparemela.com

Much Ado About VAT Administration in Nigeria

Much Ado About VAT Administration in Nigeria
thisdaylive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thisdaylive.com Daily Mail and Mail on Sunday newspapers.

Bahamas was near top of tax-to-GDP ratio increase in LAC region pre-COVID, IDB study finds

“The COVID-19 pandemic caused a sharp decline in tax and resource revenues in 2020” NASSAU, BAHAMAS The Bahamas saw the second largest increase in tax-to-GDP ratios between the two years preceding the onset of the COVID-19 pandemic, according to a recently released Inter-American Development Bank (IDB) analysis. According to the Revenue Statistics in Latin America and the Caribbean 2021 analysis, the largest increases in tax-to-GDP ratios between 2018 and 2019 occurred in Nicaragua with a rise of 2.7 percentage points (23.2-25.9) and The Bahamas with a rise of two percentage points in total tax revenue as a percentage of GDP, from 16.7 in 2019 to 18.7 in 2019. According to the IDB, the analysis shows that the average tax-to-GDP ratio in the LAC region rose to 22.9 percent in 2019, an increase of 0.3 percentage points, due largely to increases in the Caribbean sub-region.

SARS-CoV-2 COVID Vaccine Market Demands, Growth, Size, Supply and Key Players are Pfizer, BioNTech, Moderna, AstraZeneca, Novovax, J&J and Others

Share this article Share this article PUNE, India, April 27, 2021 /PRNewswire/ ReportnReports provides a comprehensive overview of the size of the SARS-CoV-2 COVID Vaccine market, segmentation of the industry (by geography and vaccine technology), key players and the vast potential of vaccines that are in clinical trials. Kelly Scientific analysis indicates that the global COVID vaccine market was worth $59 billion in 2021. However, our forecast indicates that an initial drop in 2022 will occur due to a number of factors including single booster shots as opposed to two shot vaccines and reduced prices in vaccines due to competition. The COVID vaccine industry is expected to then grow significantly at a CAGR of over 9% and reach $47.5 billion by 2026. This is due to an opening up of the market from a closed government dominated space to one in which private healthcare providers and companies can purchase vaccines. There will also be a continued significant un-met need for vaccine

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.